The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors

Yazar: Bechman, Katie, Yates, Mark, Galloway, James B.
Yayımlandı Pharmacol Res (2019)

Corrigendum to “The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors” [Pharmacol. Res. 147 (2019) 104392]

Yazar: Bechman, Katie, Yates, Mark, Galloway, James B.
Yayımlandı Pharmacol Res (2020)

The immunosuppressed traveler: infection risks with autoimmunity and immunosuppression, vaccinations, and general travel advice

Yazar: Allen, Victoria, Longley, Nicky, Galloway, James B., Bechman, Katie
Yayımlandı Handbook of Systemic Autoimmune Diseases (2020)

Placebo response in rheumatoid arthritis clinical trials

Yazar: Bechman, Katie, Yates, Mark, Norton, Sam, Cope, Andrew, Galloway, James B
Yayımlandı J Rheumatol (2019)

A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis

Yazar: Bechman, Katie, Dalrymple, Anthony, Southey-Bassols, Charles, Cope, Andrew P., Galloway, James B.
Yayımlandı BMC Rheumatol (2020)

Remote Measurement in Rheumatoid Arthritis: Qualitative Analysis of Patient Perspectives

Yazar: White, Katie M, Ivan, Alina, Williams, Ruth, Galloway, James B, Norton, Sam, Matcham, Faith
Yayımlandı JMIR Form Res (2021)

Components of treatment delay in rheumatoid arthritis differ according to autoantibody status: validation of a single-centre observation using national audit data

Yazar: Pratt, Arthur G., Lendrem, Dennis, Hargreaves, Ben, Aslam, Osman, Galloway, James B., Isaacs, John D.
Yayımlandı Rheumatology (Oxford) (2016)

Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology...

Yazar: Bechman, Katie, Oke, Anuoluwapo, Yates, Mark, Norton, Sam, Dennison, Elaine, Cope, Andrew P, Galloway, James B
Yayımlandı Rheumatology (Oxford) (2020)

Corrigendum to: Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society f...

Yazar: Bechman, Katie, Oke, Anuoluwapo, Yates, Mark, Norton, Sam, Dennison, Elaine, Cope, Andrew P, Galloway, James B
Yayımlandı Rheumatology (Oxford) (2020)

Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti‑TNF therapy: results from the British Society for Rheumatology Biologics Register...

Yazar: Davies, Rebecca, Galloway, James B, Watson, Kath D, Lunt, Mark, Symmons, Deborah P M, Hyrich, Kimme L
Baskı/Yayın Bilgisi 2011

Data quality predicts care quality: findings from a national clinical audit

Yazar: Yates, Mark, Bechman, Katie, Dennison, Elaine M., MacGregor, Alexander J., Ledingham, Jo, Norton, Sam, Galloway, James B.
Yayımlandı Arthritis Res Ther (2020)

A Kawasaki-like illness in an adult with recent SARS-CoV-2 infection

Yazar: Nagra, Deepak, Russell, Mark D, Rosmini, Stefania, Sado, Daniel, Buazon, April, Shafi, Taimur, Hamlyn, Elizabeth, Sandhu, Gurjinder, Rutherford, Andrew I, Galloway, James B
Yayımlandı Rheumatol Adv Pract (2021)

The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology B...

Yazar: Mercer, Louise K, Green, Adele C, Galloway, James B, Davies, Rebecca, Lunt, Mark, Dixon, William G, Watson, Kath D, Symmons, Deborah PM, Hyrich, Kimme L
Baskı/Yayın Bilgisi 2012

Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population

Yazar: Mercer, Louise K., Davies, Rebecca, Galloway, James B., Low, Audrey, Lunt, Mark, Dixon, William G., Watson, Kath D., Symmons, Deborah P. M., Hyrich, Kimme L.
Baskı/Yayın Bilgisi 2013

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results fro...

Yazar: Galloway, James B., Hyrich, Kimme L., Mercer, Louise K., Dixon, William G., Fu, Bo, Ustianowski, Andrew P., Watson, Kath D., Lunt, Mark, Symmons, Deborah P. M.
Baskı/Yayın Bilgisi 2011

Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Yazar: Mercer, Louise K, Galloway, James B, Lunt, Mark, Davies, Rebecca, Low, Audrey L S, Dixon, William G, Watson, Kath D, Symmons, Deborah P M, Hyrich, Kimme L
Yayımlandı Ann Rheum Dis (2017)

Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis—a proof of principle and exploratory trial: is dose tapering practical in good responders?

Yazar: Ibrahim, Fowzia, Lorente-Cánovas, Beatriz, Doré, Caroline J, Bosworth, Ailsa, Ma, Margaret H, Galloway, James B, Cope, Andrew P, Pande, Ira, Walker, David, Scott, David L
Yayımlandı Rheumatology (Oxford) (2017)

Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics...

Yazar: Galloway, James B, Mercer, Louise K, Moseley, Alison, Dixon, William G, Ustianowski, Andrew P, Helbert, Matthew, Watson, Kath D, Lunt, Mark, Hyrich, Kimme L, Symmons, Deborah PM
Baskı/Yayın Bilgisi 2013

Biological responses to COVID-19: Insights from physiological and blood biomarker profiles

Yazar: Zakeri, Rosita, Pickles, Andrew, Carr, Ewan, Bean, Daniel M., O’Gallagher, Kevin, Kraljewic, Zeljko, Searle, Tom, Shek, Anthony, Galloway, James B, Teo, James T.H., Shah, Ajay M., Dobson, Richard J.B., Bendayan, Rebecca
Yayımlandı Curr Res Transl Med (2021)

IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regression

Yazar: Tharmarajah, Emmanuel, Buazon, April, Patel, Vishit, Hannah, Jennifer R., Adas, Maryam, Allen, Victoria B., Bechman, Katie, Clarke, Benjamin D., Nagra, Deepak, Norton, Sam, Russell, Mark D., Rutherford, Andrew I., Yates, Mark, Galloway, James B.
Yayımlandı J Infect (2021)